Eledon Pharmaceuticals Inc
ELDN1.600USD
+0.030+1.91%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
95.81MMarket Cap
5.87P/E TTM
Eledon Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.75
54.49%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.745, with a year-on-year change of 54.49%.
What is the net income of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its net income was -36.18M, with a year-on-year change of 68.95%.
What is the net margin of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -35.90%, with a year-on-year change of 25.39%.
What is the Return on Assets (ROA) of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -27.16%, with a year-on-year change of 38.76%.
What is the operating profit of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -70.58M, with a year-on-year change of -64.13%.
What are the current assets of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its current assets were 143.73M, with a year-on-year change of 156.07%.
What are the total assets of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its total assets of Eledon Pharmaceuticals Inc were 177.41M, with a year-on-year change of 99.18%.
What are the total liabilities of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Eledon Pharmaceuticals Inc were 59.27M, with a year-on-year change of 949.50%.
What is the total equity of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its total equity of Eledon Pharmaceuticals Inc was 118.14M, with a year-on-year change of 41.62%.
What is the net operating income of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Eledon Pharmaceuticals Inc was -36.18M, with a year-on-year change of 68.95%.
What is the net investment of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its net investment of Eledon Pharmaceuticals Inc was -70.31M, with a year-on-year change of -55.26%.
What is the net financing of Eledon Pharmaceuticals Inc?
According to Eledon Pharmaceuticals Inc's FY2024 earnings report, its net financing of Eledon Pharmaceuticals Inc was 133.52M, with a year-on-year change of 304.40%.
